Roswell Park Sees Suggestion of Benefit in First Clinical Trial to Combine Beta-Blocker and Checkpoint Inhibitor
October 31, 2020
October 31, 2020
BUFFALO, New York, Oct. 31 (TNSJou) -- The Roswell Park Comprehensive Cancer Center issued the following news release on Oct. 30:
The same biochemical triggers that spur a "fight or flight" response when we encounter threats may help tumor cells to thrive. A team of researchers from Roswell Park Comprehensive Cancer Center is looking at ways to disrupt that dynamic so that cancer treatments can be more effective. Their latest work, published today in Clinical Cancer Resear . . .
The same biochemical triggers that spur a "fight or flight" response when we encounter threats may help tumor cells to thrive. A team of researchers from Roswell Park Comprehensive Cancer Center is looking at ways to disrupt that dynamic so that cancer treatments can be more effective. Their latest work, published today in Clinical Cancer Resear . . .